CA2420859C - Microneedle structure and production method therefor - Google Patents

Microneedle structure and production method therefor Download PDF

Info

Publication number
CA2420859C
CA2420859C CA002420859A CA2420859A CA2420859C CA 2420859 C CA2420859 C CA 2420859C CA 002420859 A CA002420859 A CA 002420859A CA 2420859 A CA2420859 A CA 2420859A CA 2420859 C CA2420859 C CA 2420859C
Authority
CA
Canada
Prior art keywords
microneedle
slots
wafer
etching process
substantially straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002420859A
Other languages
French (fr)
Other versions
CA2420859A1 (en
Inventor
Yehoshua Yeshurun
Meir Hefetz
Meint De Boer
J. W. Berenschot
J. G. E. Gardeniers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanopass Ltd
Original Assignee
Nanopass Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL13813100A external-priority patent/IL138131A0/en
Application filed by Nanopass Ltd filed Critical Nanopass Ltd
Publication of CA2420859A1 publication Critical patent/CA2420859A1/en
Application granted granted Critical
Publication of CA2420859C publication Critical patent/CA2420859C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B81—MICROSTRUCTURAL TECHNOLOGY
    • B81C—PROCESSES OR APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OR TREATMENT OF MICROSTRUCTURAL DEVICES OR SYSTEMS
    • B81C1/00—Manufacture or treatment of devices or systems in or on a substrate
    • B81C1/00436—Shaping materials, i.e. techniques for structuring the substrate or the layers on the substrate
    • B81C1/005—Bulk micromachining
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053—Methods for producing microneedles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B81—MICROSTRUCTURAL TECHNOLOGY
    • B81B—MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES
    • B81B2203/00—Basic microelectromechanical structures
    • B81B2203/03—Static structures
    • B81B2203/0361—Tips, pillars

Abstract

A method for processing a wafer to form a plurality of hollow microneedles projecing from a substrate includes forming, by use of a dry etching process , a number of groups of recessed features, each including at least one slot deployed to form an open shape having an included area and at least one hole located within the included area. The internal surfaces of the holes and the slots are then coated with a protective layer. An anisotropic wet etching process is then performed in such a manner as to remove material from outsid e the included areas while leaving a projecting feature within each of the included areas. The protective layer is then removed to reveal the microneedles.

Description

Microneedle Structure and Production Method Therefor FIELD AND BACKGROUND OF THE INVENTION

The present invention relates to microneedle structures and, in particular, it concerns a microneedle production method and the microneedle structure produced thereby.
Much research has been directed towards the development of microneedles formed on chips or wafers by use of micro-machining techniques. This approach promises the possibility of producing numerous, very small needles which are sufficient to form small perforations in the dermal barrier, thereby overcoming the molecular size limitations of conventional transdermal patches, while being safe for use by unqualified personnel. Examples of such work may be found in PCT
Publication No. WO 99/64580 to Georgia Tech Research Corp., as well as in the following scientific publications: "Micro machined needles for the transdermal delivery of drugs", S.H.S. Henry et al. (MEMS 98, Heildelberg, Germany, Jan.
1998);
"Three dimensional hollow micro needle and microtube arrays", D.V. McAllister et al. (Transducer 99, Sendai, Japan, Jun. 1999); "An array of hollow micro-capillaries for the controlled injection of genetic materials into animal/plant cells", K.
Chun et al.
(MEMS 99, Orlando, Fl., Jan. 1999); and "Injection of DNA into plant and animal tissues with micromechanical piercing structures", W. Trimmer et al. (IEEE
workshop on MEMS, Amsterdam, Jan. 1995). The more recent of these references, namely, the Georgia Tech application and the Chun et al. reference, disclose the use of hollow microneedles to provide a flow path for fluid flow through the skin barrier.
While hollow microneedles are potentially an effective structure for delivering fluids across the dermal barrier, the structures proposed to-date suffer from a number of drawbacks. Most notably, the proposed structures employ microneedles with flat hollow tips which tend to punch a round hole through the layers of skin. This punching action tends to cause damage to the skin. Additionally, the punched material tends to form a plug which at least partially obstructs the flow path through the microneedle. This is particularly problematic where withdrawal of fluids is required since the suction further exacerbates the plugging of the hollow tube within the microneedle. The flat ended form of the needles also presents a relatively large resistance to penetration of the skin, reducing the effectiveness of the structure.
A further group of proposed devices employ microneedles formed by in-plane production techniques. Examples of such devices are described in U.S. Patents Nos.
5,591,139 to Lin et al., 5,801,057 to Smart et al., and 5,928,207 to Pisano et al. The use of in-plane production techniques opens up additional possibilities with regard to the microneedle tip configuration. This, however, is at the cost of very limited density of microneedles (either a single microneedle, or at most, a single row of needles), leading to corresponding severe fluid flow rate limitations. The very long proposed needle (about 3 mm) of Smart et al. suffers from an additional very high risk of needle breakage.

U. S. Patent No. 6,558,361 issued May 6, 2003 proposes an.
improved out-of-plane hollow microneedle structure having an aperture which is located behind a non-hollow piercing tip. The application describes a number of production tecluliques for such structures, including techniques based upon either dry etching or by combining wet etching techniques with asynimetric abrasion.
While the techniques described in the aforementioned co-pending application produce highly effective microneedle structures, various disadvantages are encountered while implementing such techniques in commercial production.
Firstly, conventional deep reactive ion etching (DRIE) is generally sufficiently inaccurate to reduce the usable yield to unacceptably low proportions. Accuracy can be greatly improved by using cryogenic dry etching techniques. This option, however, greatly reduces the rate at which material can be etched away. As a result, these techniques are inef.ficient`i or,.processing large areas of a wafer. Wet techniques, on the other hand, are efficient for siniultaneous processing of large regions of a wafer and offer high accuracy. Wet techniques are not, however, suited for directly achieving the asymmetrical forms required for implementation of the rnicroneedles.
A further shortcoming of microneedle structures made by micromachining techniques is the brittleness of the resulting microneedles. Microneedles made from silicon or silicon dioxide are highly brittle. As a result, a significant proportion of the microneedles may fracture due to the stresses occurring during penetration, leaving fragments of the material within the tissue. Furthermore, oblique insertion by an unskilled person could lead to fracture of a very large proportion of the needles, resulting in malfunction of the device.
There is therefore a need for a method for producing hollow microneedles which would combine the advantages of dry and wet etching techniques to offer an effective and reliable production technique. It would also be highly advantageous to provide microneedle structures produced by such production methods.

SUMMARY OF THE INVENTION

The present invention is a method for producing hollow microneedles using a sequence of dry and wet etching techniques, and a hollow microneedle structure produced by such techniques.
According to the teachings of the present invention there is provided, a method for processing a wafer to fonn at least one hollow microneedle projecting from a substrate, the method comprising the steps of: (a) forming by use of a dry etching process at least one group of recessed features, each group of recessed features including at least one slot deployed to form an open shape having an included area and at least one hole located within the included area; (b) coating internal surfaces of the holes and the slots with a protective layer; (c) performing an anisotropic wet etching process in such a manner as to remove material from outside the included areas while leaving a projecting feature within each of the included areas;
and (d) removing the grote,ctive layer.
According to a fi.irther feature of the present invention, the open shape is substantially a V-shape formed from two substantially straight slots.
According to a further feature of the present invention, the V-shape is modified by a minimum radius of curvature at the intersection of the two substantially straight slots.
According to a further feature of the present invention, the two substantially straight slots subtend an angle of between about 30 and about 120 therebetween.
According to a further feature of the present invention, the two substantially straight slots subtend an angle of between about 85 and about 95 therebetween.
According to a further feature of the present invention, the dry etching process employs deep reactive ion etching.
According to a further feature of the present invention, the dry etching process includes cryogenic dry etching.
According to a further feature of the present invention, a minimum transverse dimension of the hole is greater than a minimum transverse dimension of the slots such that the hole extends to a depth greater than the slots.
According to a further feature of the present invention, a plurality of connecting holes are formed penetrating into a face of the wafer opposite to the projections such that the each of the connecting holes interconnects with a corresponding one of the holes to form a through channel for fluid flow.
According to a further feature of the present invention, the wet etching process employs a solution containing potassium hydroxide.
According to a further feature of the present invention, the wet etching process is performed in such a manner as to selectively remove material from within the included areas such that each of the projecting features exhibits an inclined upper surface sloping upward from the substrate.
According to a further feature of the present invention, the at least one group of recessed featti`res`,is implemented as a plurality of groups of recessed features for forming a two-dimensional array of hollow microneedles.
According to a further feature of the present invention, a mold of the at least one hollow microneedle projecting from the substrate is formed for use in micro-injection-molding.
There is also provided according to the teachings of the present invention, a microneedle structure integrally formed so as to project from a surface of a wafer, the surface corresponding substantially to a <100> crystallographic plane, the microneedle structure comprising: (a) at least one wall standing substantially perpendicular to the wafer surface; (b) an inclined surface corresponding to a crystallographic plane and extending from the wafer surface to an intersection with the at least one wall; and (c) a fluid flow channel extending from the inclined surface through to an opposing face of the wafer.
According to a further feature of the present invention, the at least one wall includes at least two substantially straight wall portions together forming a V-shape.
According to a further feature of the present invention, the at least one wall further includes a curved portion interconnecting the at least two substantially straight wall portions.
According to a further feature of the present invention, the two substantially straight wall portions subtend an angle of between about 30 and about 120 therebetween.
According to a further feature of the present invention, the two substantially straight wall portions subtend an angle of between about 85 and about 95 therebetween.
According to a further feature of the present invention, the inclined surface corresponds substantially to a<111> crystallographic plane.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention is herein described, by way of example only, with reference to the accompanying drawings, wherein:
FIGS. 17A=1D are schematic isometric views illustrating four stages of a method for producing hollow microneedles according to the teachings of the present invention;
FIGS. 2A-2F are schematic cross-sectional views illustrating more fully the method of Figures lA-1D;

FIGS. 3A-3D are plan views of a number of alternative slot forms which may be used to implement the method of the present invention;
FIG. 4 is an enlarged isometric view of an array of hollow microneedles fonned by the method of the present invention of a wafer surface;
FIG. 5 is a further enlarged isometric view of one of the microneedles from Figure 4; and FIG. 6 is an enlarged isometric view of an array of a second form of hollow microneedles formed by the method of the present invention of a wafer surface.
DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention is a method for producing hollow microneedles using a sequence of dry and wet etching techniques, and a hollow microneedle structure produced by such techniques.
The principles and operation of production techniques and the resulting structures according to the present invention may be better understood with reference to the drawings and the accompanying description.

Turning now to the drawings, Figures lA-1D and 2A-2F illustrate schematically a method for processing a wafer 10 to form a plurality of hollow microneedles 12 projecting from a substrate 14.
Generally speaking, the method first employs a dry etching process to form a plurality of groups of recessed features, each group of recessed features including at least one slot 16 deployed to form an open shape having an included area 18 and at least one hole 201ocated within included area 18. One such group of features is shown in Figures 1 A and 2A.
Internal surfaces of holes 20 and slots 16 are then coated with a protective layer 22 (Figures 1'B dnd 2D) prior to performing an anisotropic wet etching process to remove material substantially uniformly from outside included areas 18 while leaving a projecting feature, corresponding to microneedles 12, within each included area 18.
This stage is shown in Figures 1 C and 2E. Protective layer 22 is then removed, .. .. ..... _ . ,.,_ . ... ~õ~..,~,~.,~~., leaving microneedles 12 projecting from the surface of the substrate 14 (the remaining thickness of the initial wafer 10), as shown in Figures 1D and 2F.
It will be immediately appreciated that this process offers a highly efficient and reliable production technique for hollow microneedles. Specifically, since the volume of material to be removed by the dry etching process is small, highly accurate techniques, such as cryogenic DRIE, may be used to advantage without unduly lengthening the production time. The subsequent use of wet etching techniques then allows larger volumes of material to be removed quicldy and accurately to achieve a high yield finished product. The structure of the resulting microneedles is highly robust and may be used to advantage for transdermal drug delivery and/or diagnostic sampling, for example, as part of the devices and systems described in the aforementioned U.S. Patent No. 6,558,361.
- This and other advantageous of the method and corresponding structures of the present invention will be better understood from the followiuag more detailed description.
Before turning to the features of the present invention in more detail, it will be helpful to clarify certain terminology as it is to be used throughout the description and claims. Firstly, the terms "dry etching process" and "wet etching process" are used according to their accepted usage to refer to etching processes in which the primary etching step is performed by exposure to a solution ("wet") or by other means ("dry").
Clearly, these terms do not exclude the use of additional preparatory or subsequent "dry" processing steps in a wet etching process, or vice versa.
The term "wafer" is used herein to refer to the material from which the microneedles are to be formed. Typically, the wafers used are single crystal wafers, most preferably of cubic structure such as silicon. The term "substrate" is used for the underlying structur.e upon which the microneedles are supported. Clearly, the substrate thus defined is generally a remaining thickness of the original wafer after completion of the processing.
The term "niicroneedle" is used herein to refer to a projection formed on a surface of a substrate. For transdermal fluid transfer applications, microneedles are configured to project to a maximum height above the substrate of no more than 2 mm, and typically no more than 500 m. Further details of the design considerations in choosing dimensions of the microneedles for various applications are discussed in the aforementioned co-pending application and will not be dealt with here.
The term "hollow" is used to refer to a microneedle structure through which a fluid flow conduit passes, in contrast to a "solid microneedle" which lacks such a conduit. It should be noted that the conduit is typically a small proportion of the volume of the microneedle projection.
Finally, use will be made herein of various geometric terminology.
Specifically, the term "open shape" is used to refer to a shape formed by one or more contiguous line which does not close on itself. Despite this lack of closure, reference is made to an "enclosed area" defined by the open shape. This enclosed area is defined to be the largest contiguous area which can be enclosed by adding a single straight line to the open shape. The open shape is chosen such that the enclosed area is non-zero, i.e., it is not a single straight line.
Turning now to the features of the present invention in more detail, the various stages of a preferred implementation of the production process will be described with reference to Figures 2A-2F.
Firstly, Figure 2A shows wafer 10 after the dry etching process. Preferably, as mentioned above, high accuracy is achieved by using cryogenic DRIE or other high-accuracy dry etching processes. The wafer is first prepared, as is known in the art, by cleaning followed by lithography to prepare a mask for the DRIE. Preferably, a minimum transverse dimension of hole 20 is greater than a minimum transverse dimension of slots 16. As a result, hole 20 is etched at a slightly greater rate than slot 16, so that the hole extends to a greater depth. Typical values for the width of slots 16 are in the range of about 10 to about 20 microns. The dimensions of hole 20 are generally in the range of 20-150 micron, chosen as a function of the dimensions of the microneedles to be produced.
Referring briefly to Figures 3A-3D, it should be noted that a wide range of different configurations may be used for the open shape formed by slot(s) 16.
In one preferred example shown in Figure 3A, the open shape is a V-shape formed from two substantially straight slots 16a and 16b. Figure 3B shows a more preferred example where the V-shape is modified by a curved connecting slot 16c having a given minimum radius of curvature at the intersection of the two substantially straight slots 16a and 16b. This minimum radius of curvature preferably has a value in the range of about 5 m to about 100 m, and most preferably in the range of 10-50 m. The latter shape is believed to result in a more robust microneedle tip. In both cases, slots 16a and 16b preferably subtend an angle of between about 30 and about 120 . The specific choice of angle between these slots for a given application is dictated by the dimensions needed for the base of the needle. Specifically, the smaller the enclosed angle between the slots, the smaller the needle base will be. In certain applications, there may be an advantage to a choice of angle between about 60 and about 100 .
Although the aforementioned slot shapes are believed to be preferred, it should be noted that a wide range of other forms are also effective and may, in some cases, offer certain advantages. By way of example, Figure 3C shows a slot configuration similar to Figure 3B in which curved slot 16c is replaced by a third straight slot 16d.
Figure 3D shows a further example where the entire slot 16 is implemented as a single graduated curved form approximating to a U-shape.
It will be noted that the choice of open shape formed by slot(s) 16 and its orientation with respect to the crystal axes must be chosen in accordance with the intended wet etch process so as to form the required projecting microneedle.
By way of example, in the case of the preferred KOH etch, the open shape must be sufficiently enclosed to inhibit the rapid etching of the <100> plane within the contained area, thereby allowing the required microneedle structure to form by etching of the <111>
plane which occurs much more slowly in KOH. To form a symmetrical microneedle, the line that bisect& the angle between slots 16a and 16b should be perpendicular to a <110> plane. In a most preferred example illustrated herein, the slots correspond substantially to two <100> planes.
The length dimensions of slot 16 are chosen according to the size of microneedle required.
Hole 20 also may vary in shape. In some cases, a circular hole may be preferred. An asymmetric hole, typically roughly elliptical, is often more advantageous, allowing an increase of the cross-section (and hence flow capacity) of the hole without coming overly close to slots 16. Optionally, other forms, such as a hole approximating to a triangular form, could be used to achieve similar results.
Turning now to Figure 2B, it is a particularly preferred feature of the process and structure of the present invention that holes 20 are connected in fluid flow connection with the rear surface 24 of substrate 14 to allow fluid transfer via microneedles 12. To this end, a plurality of connecting holes 26 are preferably formed, penetrating into surface 24 such that each of connecting hole 26 interconnects with a corresponding hole 20 to form a through channel.
Connecting holes 26 are typically formed by back-side processing similar to that used for holes 20 and slots 16 on the front-side of the wafer.
Precautions must be taken to ensure proper alignment of the front-side and back-side masks, as is known in the art. The tolerance of the alignment is preferably increased slightly by employing connecting holes 26 of diameter greater than the dimensions of front-side holes 20.
The connecting holes are preferably centered slightly further away from slots 16 in order to avoid accidental perforation of the substrate via the slots. The depth differential between holes 20 and slots 16 provides an additional safeguard against this problem.
The order of processing of the front and back surfaces of the wafer is generally not critical, and depends primarily on practical logistical considerations.
Thus, the back-side processing can be performed prior to any front-side processing, or between the dry and wet etching steps. Typically, however, the back-side processing should be performed prior to the wet etching step in order to avoid damage to the microneedles which are theii formed on the front surface. Additionally, it may be advantageous to perform the front-side dry etch first to allow slight "over etching", i.e., etching to slightly greater than the theoretical required depth to ensure intersection with the back-side holes.

Turning now to Figures 2C, 2D and 2E, the choice of material for protective coating 22 must be suited to the type of wet etch process to be performed. In a particularly preferred implementation, the wet etching process employs a solution containing potassium hydroxide (KOH). A suitable protective coating material for such an implementation is SiRN. In order to achieve selective coating of the insides of holes 20 and slots 16, the coating is typically performed in two steps: first, a uniform coating over all exposed surfaces (Figure 2C), such as by low pressure chemical vapor deposition (LPCVD); then, selective removal of the coating from the upper surface (Figure 2D), such as by reactive ion etching (RIE), while leaving the coating within the holes and slots.
The anisotropic wet etching process then removes the upper surface of the wafer, generally keeping to the <100> horizontal crystallographic plane. Only where the etching process is asymmetrically limited by partial enclosure within walls formed by protective coating 22, the anisotropic wet etching process adopts alternative crystallographic forms, leading to formation of projections 12 (Figure 2E).
The protective coating 22 is then removed, typically by a further wet etching process. In the aforementioned example, the protective coating material is effectively removed by a hydrogen fluoride (HF) etch.
It will be noted that the pyramid-like structure of the microneedles produced by the method of the present invention is generally highly robust, thereby greatly reducing the likelihood of fracture during use of the microneedles. This robustness is further enhanced by the modification of the pyramid-like structure to include a rounded-wall configuration of Figures lA-1D, 3B and 6. Nevertheless, in certain cases, the resulting structure may optionally be further processed by addition of various coating layers to provide additional desirable properties, as will now be described.
Firstly, depending upon the wafer material, it may be preferable to coat at least the microneedles with a layer of bio-compatible material, typically a metal or metal alloy. For this purpose, a coating of about 2 m titanium or stainless steel is typically sufficient. Thicker coating of at least 10-20 m may also serve a structural safety function, tending to prevent fragments being left behind in the event that a brittle silicon needle might fracture.
According to a further preferred option, a layer of at least about 20 pm of a super-elastic alloy is deposited over at least the conical projections. An example of such an alloy is the range of NiTi alloys generally known as Nitinol. This offers a still further enhanced level of structural safety by providing a layer which is not prone to breaking or fracturing under a very wide range of operating conditions.
One preferred technique for forming the aforementioned metallic layers is sputtering. Sputtering techniques for applying NiTi are discussed in "Micromachining Process for thin film SMA actuators", Nakamura et al. (IEEE, February 1996).
In order to achieve the required NiTi stoichiometry to produce super elastic properties, it is recommended to use a target such as micro needles pre-coated with a small amount of Ti or Ni. Increasing or decreasing the amount of Ni or Ti or any ternary element can result in a film transformation which is the basic principle of super alloy properties of any desired composition. The exact composition defines the temperature at which the super elastic behavior is exhibited. It has also been demonstrated that adjusting the target to substrate distance and sputtering gas pressure can change the NiTi stoichiometry from 47% to 52% Ti, while using a 50% Ti target. Such changing in the stoichiometry could produce super elastic properties at about room temperature.
The deposited amorphous films must be annealed to achieve crystallinity. This annealing also promotes adhesion to the substrate through formation of a thin reaction layer (-40nm). For equi-atomic NiTi , no change of thin film phase transformation as observed when annealing between 500-700 C, However Ti-rich film displays an increased transformation temperature while Ni-rich film displays a decreased temperature transformation. Thin film can recover from 6% strain at 600 MPa forces which is above the,.need for microneedle configurations.
In yet a further option, at least part of the substrate material is removed by etching away from under. the metallic or super-elastic layer so as to leave the microneedle projections formed substantially exclusively from the layer of metallic material or super-elastic alloy. In the most highly preferred case of a super-elastic alloy, this results in a microneedle array which is effectively unbreakable under a wide range of conditions. This provides a highly valuable solution to the problem of fractured microneedles associated with the prior art, and provides a greatly improved level of safety against damage to the device or harm to the user if the needles are inserted improperly at an oblique angle to the skin.
While the microneedle structures and production techniques described thus far may be used directly to advantage in a wide range of applications, it may in some cases be preferably to provide a microneedle structure made from polymer materials.
For such applications, the production technique of the present invention is preferably supplemented by a further step of fonning a mold of the hollow microneedle structure.
The procedures for forming such a mold, as well as the subsequent micro-injection-molding techniques for reproducing the structure using the mold, are well known in the field.
Although shown here schematically with a single microneedle, the process described is clearly well suited to producing a one- or two-dimensional arrays of microneedles projecting from the surface of substrate 12 with any desired spacing, layout and dimensions. In fact, the present invention relates to a wide range of applications from a single needle chip up to large scale two-dimensional arrays of needles with a density of several hundreds per square centimeter. It is a particularly preferred feature of the microneedle structures according to certain implementations of the present invention that a two-dimensional array including at least 20 microneedles is provided. More preferably, at least 50 microneedles are provided on each chip, and most preferably, at least 100. In many practical applications, large arrays of several hundreds of microneedles may be formed on a chip of less than 1 cm2. The spacing between centers of adjacent microneedles in a given direction is typically in tlre range of 2-10 times the maximum dimension of each needle in that direction.
Turning finally to Figures 4-6, these illustrate the microneedle structure resulting from the production process described above. Specifically, Figures 4 and 5 show an array of microneedles formed from the slot pattern of Figure 3A, while Figure 6 shows a corresponding array formed using the pattern of Figure 3B.
In each case, the resulting structure includes an array of microneedles integrally formed so as to project from a wafer surface corresponding substantially to a <100>
crystallographic plane. Each microneedle has at least one wall standing substantially perpendicular to the wafer surface, an inclined surface corresponding to a crystallographic plane and extending from the wafer surface to an intersection with the at least one wall, and a fluid flow channel extending from the inclined surface through to an opposing face of the wafer. The intersection of the fluid flow channel with the inclined surface offers an enlarged opening, thereby enhancing the capabilities of the microneedle for fluid transfer, and particularly diagnostic sample withdrawal, across a skin barrier.
In the preferred example described above employing KOH, the inclined surface corresponds substantially to a <111> crystallographic plane.

It will be appreciated that the above descriptions are intended only to serve as examples, and that many other embodiments are possible within the spirit and the scope of the present invention.

Claims (19)

WHAT IS CLAIMED IS:
1. A method for processing a wafer to form at least one hollow microneedle projecting from a substrate, the method comprising the steps of:
(a) forming by use of a dry etching process at least one group of recessed features, each group of recessed features including at least one slot deployed to form an open shape having an included area and at least one hole located within said included area;
(b) coating internal surfaces of said holes and said slots with a protective layer;
(c) performing an anisotropic wet etching process in such a manner as to remove material from outside said included areas while leaving a projecting feature within each of said included areas; and (d) removing said protective layer.
2. The method of claim 1, wherein said open shape is substantially a V-shape formed from two substantially straight slots.
3. The method of claim 2, wherein said V-shape is modified by a minimum radius of curvature at the intersection of said two substantially straight slots.
4. The method of claim 2, wherein said two substantially straight slots subtend an angle of between about 30° and about 120°
therebetween.
5. The method of claim 2, wherein said two substantially straight slots subtend an angle of between about 85° and about 95°
therebetween.
6. The method of claim 1, wherein said dry etching process employs deep reactive ion etching.
7. The method of claim 1, wherein said dry etching process includes cryogenic dry etching.
8. The method of claim 1, wherein a minimum transverse dimension of said hole is greater than a minimum transverse dimension of said slots such that said hole extends to a depth greater than said slots.
9. The method of claim 8, further comprising forming a plurality of connecting holes penetrating into a face of said wafer opposite to said projections such that said each of said connecting holes interconnects with a corresponding one of said holes to form a through channel for fluid flow.
10. The method of claim 1, wherein said wet etching process employs a solution containing potassium hydroxide.
11. The method of claim 1, wherein said wet etching process is performed in such a manner as to selectively remove material from within said included areas such that each of said projecting features exhibits an inclined upper surface sloping upward from said substrate.
12. The method of claim 1, wherein said at least one group of recessed features is implemented as a plurality of groups of recessed features for forming a two-dimensional array of hollow microneedles.
13. The method of claim 1, further comprising forming a mold of said at least one hollow microneedle projecting from the substrate for use in micro-injection-molding.
14. A microneedle structure integrally formed so as to project from a surface of a wafer, the surface corresponding substantially to a <100>
crystallographic plane, the microneedle structure comprising:

(a) at least one wall standing substantially perpendicular to the wafer surface;

(b) an inclined surface corresponding to a crystallographic plane and extending from the wafer surface to an intersection with said at least one wall; and (c) a fluid flow channel extending from said inclined surface through to an opposing face of the wafer.
15. The microneedle structure of claim 14, wherein said at least one wall includes at least two substantially straight wall portions together forming a V-shape.
16. The microneedle structure of claim 15, wherein said at least one wall further includes a curved portion interconnecting said at least two substantially straight wall portions.
17. The microneedle structure of claim 15, wherein said two substantially straight wall portions subtend an angle of between about 30° and about 120°
therebetween.
18. The microneedle structure of claim 15, wherein said two substantially straight wall portions subtend an angle of between about 85° and about 95°
therebetween.
19. The microneedle structure of claim 14, wherein said inclined surface corresponds substantially to a <111> crystallographic plane.
CA002420859A 2000-08-28 2001-08-28 Microneedle structure and production method therefor Expired - Lifetime CA2420859C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL138131 2000-08-28
IL13813100A IL138131A0 (en) 2000-08-28 2000-08-28 Microneedle structure and production method therefor
US09/677,175 2000-10-02
US09/677,175 US6533949B1 (en) 2000-08-28 2000-10-02 Microneedle structure and production method therefor
PCT/IL2001/000806 WO2002017985A2 (en) 2000-08-28 2001-08-28 Microneedle structure and production method therefor

Publications (2)

Publication Number Publication Date
CA2420859A1 CA2420859A1 (en) 2002-03-07
CA2420859C true CA2420859C (en) 2009-04-14

Family

ID=26323975

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002420859A Expired - Lifetime CA2420859C (en) 2000-08-28 2001-08-28 Microneedle structure and production method therefor

Country Status (6)

Country Link
US (4) US6533949B1 (en)
EP (1) EP1330274B1 (en)
JP (1) JP4750347B2 (en)
AU (2) AU8248901A (en)
CA (1) CA2420859C (en)
WO (1) WO2002017985A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11717660B2 (en) 2021-07-29 2023-08-08 Nanopass Technologies Ltd. Silicon microneedle structure and production method

Families Citing this family (220)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6533949B1 (en) * 2000-08-28 2003-03-18 Nanopass Ltd. Microneedle structure and production method therefor
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US6964804B2 (en) * 2001-02-14 2005-11-15 Shipley Company, L.L.C. Micromachined structures made by combined wet and dry etching
US6663820B2 (en) * 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
US20020195417A1 (en) * 2001-04-20 2002-12-26 Steinberg Dan A. Wet and dry etching process on <110> silicon and resulting structures
ES2352998T3 (en) 2001-06-12 2011-02-24 Pelikan Technologies Inc. LANCETA ELECTRIC ACTUATOR.
CA2448905C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Blood sampling apparatus and method
CA2448902C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
AU2002344825A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US8740973B2 (en) * 2001-10-26 2014-06-03 Icon Medical Corp. Polymer biodegradable medical device
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
JP2005518873A (en) 2002-03-04 2005-06-30 ナノ パス テクノロジーズ リミテッド Apparatus and method for fluid transport across a biological barrier
US7105103B2 (en) * 2002-03-11 2006-09-12 Becton, Dickinson And Company System and method for the manufacture of surgical blades
US7387742B2 (en) * 2002-03-11 2008-06-17 Becton, Dickinson And Company Silicon blades for surgical and non-surgical use
US7713214B2 (en) 2002-04-19 2010-05-11 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
KR20120087197A (en) 2002-07-19 2012-08-06 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Microneedle device, method of using microneedle device and method of delivering microneedle device
US7045069B2 (en) * 2002-11-14 2006-05-16 Gennady Ozeryansky Microfabrication method based on metal matrix composite technology
US7265881B2 (en) * 2002-12-20 2007-09-04 Hewlett-Packard Development Company, L.P. Method and apparatus for measuring assembly and alignment errors in sensor assemblies
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
DE10305831B4 (en) 2003-02-12 2007-01-04 Siemens Ag diagnostic device
US20050155955A1 (en) * 2003-03-10 2005-07-21 Daskal Vadim M. Method for reducing glare and creating matte finish of controlled density on a silicon surface
US20090007436A1 (en) * 2003-03-10 2009-01-08 Daskal Vadim M Silicon blades for surgical and non-surgical use
US7415299B2 (en) * 2003-04-18 2008-08-19 The Regents Of The University Of California Monitoring method and/or apparatus
EP2238892A3 (en) 2003-05-30 2011-02-09 Pelikan Technologies Inc. Apparatus for body fluid sampling
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
MXPA06001414A (en) * 2003-08-04 2006-08-25 Johnson & Johnson Method and device for enhancing transdermal agent flux.
WO2005020912A2 (en) * 2003-08-25 2005-03-10 3M Innovative Properties Company Delivery of immune response modifier compounds
US20050107742A1 (en) * 2003-09-15 2005-05-19 The Regents Of The University Of Michigan Shatter-resistant microprobes
US7785485B2 (en) * 2003-09-17 2010-08-31 Becton, Dickinson And Company System and method for creating linear and non-linear trenches in silicon and other crystalline materials with a router
WO2005033659A2 (en) 2003-09-29 2005-04-14 Pelikan Technologies, Inc. Method and apparatus for an improved sample capture device
WO2005037095A1 (en) 2003-10-14 2005-04-28 Pelikan Technologies, Inc. Method and apparatus for a variable user interface
EP1680154B1 (en) * 2003-10-31 2012-01-04 ALZA Corporation Self-actuating applicator for microprojection array
US7998119B2 (en) * 2003-11-18 2011-08-16 Nano Pass Technologies Ltd. System and method for delivering fluid into flexible biological barrier
EP1699524A4 (en) * 2003-11-18 2009-07-15 Nanopass Technologies Ltd Enhanced penetration system and method for sliding microneedles
WO2005060621A2 (en) * 2003-11-21 2005-07-07 The Regents Of The University Of California Method and/or apparatus for puncturing a surface for extraction, in situ analysis, and/or substance delivery using microneedles
CN100355470C (en) * 2003-12-26 2007-12-19 中国科学院理化技术研究所 Minisize solid silicon needle array chip and its preparation method and use
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
GB0402131D0 (en) * 2004-01-30 2004-03-03 Isis Innovation Delivery method
US8551391B2 (en) * 2004-02-17 2013-10-08 Avery Dennison Corporation Method of making microneedles
JP2007523771A (en) * 2004-02-23 2007-08-23 スリーエム イノベイティブ プロパティズ カンパニー Microneedle array molding method
WO2005091922A2 (en) * 2004-03-03 2005-10-06 Becton, Dickinson And Company Methods and devices for improving delivery of a substance to skin
WO2005087305A1 (en) * 2004-03-12 2005-09-22 Agency For Science, Technology And Research Methods and moulds for use in fabricating side-ported microneedles
US7396484B2 (en) * 2004-04-30 2008-07-08 Becton, Dickinson And Company Methods of fabricating complex blade geometries from silicon wafers and strengthening blade geometries
EP1751546A2 (en) 2004-05-20 2007-02-14 Albatros Technologies GmbH &amp; Co. KG Printable hydrogel for biosensors
US9775553B2 (en) * 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
TWI246929B (en) * 2004-07-16 2006-01-11 Ind Tech Res Inst Microneedle array device and its fabrication method
US20060030811A1 (en) * 2004-08-03 2006-02-09 Wong Patrick S Method and device for enhancing transdermal agent flux
US7560036B2 (en) * 2004-08-05 2009-07-14 Apogee Technology, Inc. System and method for drug delivery and microfluidic applications using microneedles
WO2006018642A1 (en) 2004-08-16 2006-02-23 Functional Microstructures Limited Method of producing a microneedle or microimplant
US7785459B2 (en) 2004-10-22 2010-08-31 Hewlett-Packard Development Company, L.P. Microneedles and methods of fabricating
US9339403B2 (en) * 2004-11-12 2016-05-17 Icon Medical Corp. Medical adhesive for medical devices
US7455688B2 (en) * 2004-11-12 2008-11-25 Con Interventional Systems, Inc. Ostial stent
US8007466B2 (en) * 2004-11-18 2011-08-30 Nanopass Technologies Ltd. System and method for delivering fluid into flexible biological barrier
AU2005314151B2 (en) 2004-12-07 2011-09-08 3M Innovative Properties Company Method of molding a microneedle
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
WO2006096251A2 (en) * 2005-03-03 2006-09-14 Icon Medical Corp. Improved metal alloys for medical device
US8323333B2 (en) * 2005-03-03 2012-12-04 Icon Medical Corp. Fragile structure protective coating
WO2006110197A2 (en) * 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
US7540995B2 (en) 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
US7452501B2 (en) * 2005-03-03 2008-11-18 Icon Medical Corp. Metal alloy for a stent
US20060198869A1 (en) * 2005-03-03 2006-09-07 Icon Medical Corp. Bioabsorable medical devices
JP4793806B2 (en) * 2005-03-22 2011-10-12 Ｔｔｉ・エルビュー株式会社 Iontophoresis device
WO2006101459A1 (en) * 2005-03-23 2006-09-28 Agency For Science, Technology And Research Microneedles
WO2006105146A2 (en) * 2005-03-29 2006-10-05 Arkal Medical, Inc. Devices, systems, methods and tools for continuous glucose monitoring
AU2006261899B2 (en) 2005-06-27 2012-05-10 Kindeva Drug Delivery L.P. Microneedle cartridge assembly and method of applying
BRPI0616165A2 (en) * 2005-09-15 2011-06-07 Tti Ellebeau Inc rod type iontophoresis device
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
JP2009509677A (en) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 Iontophoretic delivery of vesicle encapsulated active substances
AU2006299520A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
KR20080066712A (en) * 2005-09-30 2008-07-16 티티아이 엘뷰 가부시키가이샤 Functionalized microneedles transdermal drug delivery systems, devices, and methods
US7574256B2 (en) * 2005-09-30 2009-08-11 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
JP2009509634A (en) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 Functionalized microneedle transdermal drug delivery system, apparatus and method
JP2009509685A (en) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 Iontophoresis device and method for delivery of angiogenic factors to enhance healing of damaged tissue
JP2009509675A (en) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 Transdermal drug delivery systems, devices, and methods using novel pharmaceutical vehicles
US20080262416A1 (en) * 2005-11-18 2008-10-23 Duan Daniel C Microneedle Arrays and Methods of Preparing Same
EP1957132A4 (en) * 2005-12-08 2010-04-21 Nanopass Technologies Ltd Microneedle adapter for dosed drug delivery devices
EP1962679B1 (en) 2005-12-14 2012-04-11 Silex Microsystems AB Methods for making micro needles and applications thereof
US20080033338A1 (en) * 2005-12-28 2008-02-07 Smith Gregory A Electroosmotic pump apparatus and method to deliver active agents to biological interfaces
WO2007079193A2 (en) * 2005-12-30 2007-07-12 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
US9339641B2 (en) 2006-01-17 2016-05-17 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US20100168501A1 (en) * 2006-10-02 2010-07-01 Daniel Rogers Burnett Method and apparatus for magnetic induction therapy
US9610459B2 (en) * 2009-07-24 2017-04-04 Emkinetics, Inc. Cooling systems and methods for conductive coils
US7699819B2 (en) 2006-02-21 2010-04-20 The Hong Kong University Of Science And Technology Molecular sieve and zeolite microneedles and preparation thereof
US20080154107A1 (en) * 2006-12-20 2008-06-26 Jina Arvind N Device, systems, methods and tools for continuous glucose monitoring
US20090131778A1 (en) * 2006-03-28 2009-05-21 Jina Arvind N Devices, systems, methods and tools for continuous glucose monitoring
US20100049021A1 (en) * 2006-03-28 2010-02-25 Jina Arvind N Devices, systems, methods and tools for continuous analyte monitoring
WO2007123707A1 (en) * 2006-03-30 2007-11-01 Tti Ellebeau, Inc. Controlled release membrane and methods of use
CN1830496A (en) * 2006-04-10 2006-09-13 清华大学 '-'-shaped structure three-dimensional micre solid, hollow silicone meedle orknife
DE102006028781A1 (en) 2006-06-23 2007-12-27 Robert Bosch Gmbh Process for making porous microneedles and their use
WO2008007370A2 (en) * 2006-07-11 2008-01-17 Nanopass Technologies Ltd. Dual chamber injector intergrated with micro-needles
WO2008007374A2 (en) * 2006-07-12 2008-01-17 Nanopass Technologies Ltd. Microneedle devices with controlled uncapping
WO2008008291A2 (en) * 2006-07-13 2008-01-17 Icon Medical Corp. Stent
WO2008027011A1 (en) * 2006-08-28 2008-03-06 Agency For Science, Technology And Research Microneedles and methods for fabricating microneedles
US20080058726A1 (en) * 2006-08-30 2008-03-06 Arvind Jina Methods and Apparatus Incorporating a Surface Penetration Device
WO2008030497A2 (en) * 2006-09-05 2008-03-13 Tti Ellebeau, Inc. Transdermal drug delivery systems, devices, and methods using inductive power supplies
EP2063934A1 (en) * 2006-09-18 2009-06-03 Agency for Science, Technology and Research Needle structures and methods for fabricating needle structures
CA2665134A1 (en) * 2006-10-02 2008-04-10 Emkinetics, Inc. Method and apparatus for magnetic induction therapy
US11224742B2 (en) 2006-10-02 2022-01-18 Emkinetics, Inc. Methods and devices for performing electrical stimulation to treat various conditions
US9005102B2 (en) 2006-10-02 2015-04-14 Emkinetics, Inc. Method and apparatus for electrical stimulation therapy
US10786669B2 (en) 2006-10-02 2020-09-29 Emkinetics, Inc. Method and apparatus for transdermal stimulation over the palmar and plantar surfaces
US20080091226A1 (en) * 2006-10-17 2008-04-17 Nanopass Technologies Ltd. Microneedle device
CA2671069A1 (en) * 2006-12-01 2008-06-12 Tti Ellebeau, Inc. Systems, devices, and methods for powering and/or controlling devices, for instance transdermal delivery devices
US20090011158A1 (en) * 2007-03-18 2009-01-08 Nanopass Technologies Ltd. Microneedle structures and corresponding production methods employing a backside wet etch
US20080234562A1 (en) * 2007-03-19 2008-09-25 Jina Arvind N Continuous analyte monitor with multi-point self-calibration
US9114238B2 (en) 2007-04-16 2015-08-25 Corium International, Inc. Solvent-cast microprotrusion arrays containing active ingredient
EP2149149A2 (en) * 2007-05-20 2010-02-03 Nanopass Technologies Ltd. Method for producing microneedle structures employing one-sided processing
PT2175881E (en) * 2007-06-14 2012-10-22 Crucell Switzerland Ag Intradermal influenza vaccine
US20080312518A1 (en) * 2007-06-14 2008-12-18 Arkal Medical, Inc On-demand analyte monitor and method of use
US7959969B2 (en) 2007-07-10 2011-06-14 California Institute Of Technology Fabrication of anchored carbon nanotube array devices for integrated light collection and energy conversion
WO2009048607A1 (en) 2007-10-10 2009-04-16 Corium International, Inc. Vaccine delivery via microneedle arrays
GB0802447D0 (en) * 2008-02-09 2008-03-19 Univ Manchester Fluid extraction device, associated materials and methods
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
WO2010087971A2 (en) 2009-01-27 2010-08-05 California Institute Of Technology Drug delivery and substance transfer facilitated by nano-enhanced device having aligned carbon nanotubes protruding from device surface
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
EP2275164A1 (en) 2009-07-15 2011-01-19 Debiotech S.A. Multichannel micro-needles
CA2768835A1 (en) * 2009-07-23 2011-01-27 Emkinetics, Inc. Method and apparatus for magnetic induction therapy
US8834423B2 (en) 2009-10-23 2014-09-16 University of Pittsburgh—of the Commonwealth System of Higher Education Dissolvable microneedle arrays for transdermal delivery to human skin
AU2010313487A1 (en) 2009-10-26 2012-05-24 Emkinetics, Inc. Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues
US8398916B2 (en) 2010-03-04 2013-03-19 Icon Medical Corp. Method for forming a tubular medical device
US9115424B2 (en) 2010-04-07 2015-08-25 California Institute Of Technology Simple method for producing superhydrophobic carbon nanotube array
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
AU2011248108B2 (en) 2010-05-04 2016-05-26 Corium Pharma Solutions, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
US8588884B2 (en) 2010-05-28 2013-11-19 Emkinetics, Inc. Microneedle electrode
KR101180032B1 (en) 2010-07-12 2012-09-05 인싸이토(주) Method for manufacturing Hollow Microneedle with Controlled External Appearance Characteristics
WO2012079066A2 (en) 2010-12-10 2012-06-14 California Institute Of Technology Method for producing graphene oxide with tunable gap
WO2012135238A1 (en) 2011-03-29 2012-10-04 California Institute Of Technology Method to increase the capacitance of electrochemical carbon nanotube capacitors by conformal deposition of nanoparticles
AU2012323782B2 (en) 2011-10-12 2017-04-06 Vaxxas Pty Limited Delivery device
US20130110043A1 (en) 2011-10-26 2013-05-02 Nanopass Technologies Ltd. Microneedle Intradermal Drug Delivery Device with Auto-Disable Functionality
WO2013090844A1 (en) 2011-12-14 2013-06-20 California Institute Of Technology Sharp tip carbon nanotube microneedle devices and their fabrication
US20150038911A1 (en) 2012-01-24 2015-02-05 Nanopass Technologies Ltd Microneedle adapter for dosed drug delivery devices
CA3077452C (en) 2012-05-01 2022-08-09 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Tip-loaded microneedle arrays for transdermal insertion
WO2014022314A1 (en) 2012-07-30 2014-02-06 California Institute Of Technology Nano tri-carbon composite systems and manufacture
US10300260B2 (en) 2012-10-10 2019-05-28 3M Innovative Properties Company Applicator and method for applying a microneedle device to skin
US9782574B2 (en) 2012-10-10 2017-10-10 3M Innovative Properties Company Force-controlled applicator for applying a microneedle device to skin
EP2919849B1 (en) 2012-11-16 2021-01-06 Kindeva Drug Delivery L.P. Force-controlled applicator for applying a microneedle device to skin
CA2892587A1 (en) 2012-12-14 2014-06-19 Mindera Corporation Methods and devices for detection and acquisition of biomarkers
MX2015008157A (en) 2012-12-21 2016-02-22 Corium Int Inc Microarray for delivery of therapeutic agent and methods of use.
CN104884119B (en) * 2012-12-27 2018-04-20 3M创新有限公司 Product with hollow microneedles and preparation method thereof
EP2943238B1 (en) 2013-01-08 2021-05-19 Kindeva Drug Delivery L.P. Applicator for applying a microneedle device to skin
EP4094799A1 (en) 2013-03-12 2022-11-30 Corium, Inc. Microprojection applicators
CA2903583C (en) 2013-03-15 2021-12-28 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
JP2016514133A (en) 2013-03-15 2016-05-19 コリウム インターナショナル， インコーポレイテッド MICROARRAY CONTAINING FINE STRUCTURE CONTAINING NO POLYMER, MANUFACTURING METHOD AND USE METHOD
US10195409B2 (en) 2013-03-15 2019-02-05 Corium International, Inc. Multiple impact microprojection applicators and methods of use
RU2711567C2 (en) 2013-03-15 2020-01-17 Кориум, ИНК. Microchip for drug delivery and methods for use thereof
KR101712413B1 (en) 2013-03-22 2017-03-06 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Microneedle applicator comprising a counter assembly
MX353241B (en) 2013-05-31 2018-01-05 3M Innovative Properties Co Microneedle injection apparatus comprising an inverted actuator.
EP3003458B1 (en) 2013-05-31 2019-12-04 3M Innovative Properties Company Microneedle injection apparatus comprising a dual cover
SG11201509810TA (en) 2013-05-31 2015-12-30 3M Innovative Properties Co Microneedle injection and infusion apparatus and method of using same
WO2015009524A1 (en) 2013-07-16 2015-01-22 3M Innovative Properties Company Hollow microneedle with beveled tip
ES2871105T3 (en) 2013-07-16 2021-10-28 Kindeva Drug Delivery Lp Item comprising a microneedle
EP3021929B1 (en) 2013-07-16 2020-02-26 3M Innovative Properties Company Hollow microneedle with bevel opening
US10099043B2 (en) 2013-07-16 2018-10-16 3M Innovative Properties Company Hollow microneedle array article
EP3160397A4 (en) 2014-06-24 2018-03-21 Icon Medical Corp. Improved metal alloys for medical devices
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
JP6909366B2 (en) 2015-01-21 2021-07-28 キンデーバ ドラッグ デリバリー リミティド パートナーシップ Microneedle array and usage
CN107206066A (en) 2015-01-27 2017-09-26 3M创新有限公司 Aluminated coating agent for micropin vaccine patch
US10441768B2 (en) 2015-03-18 2019-10-15 University of Pittsburgh—of the Commonwealth System of Higher Education Bioactive components conjugated to substrates of microneedle arrays
WO2017004067A1 (en) 2015-06-29 2017-01-05 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US11103259B2 (en) 2015-09-18 2021-08-31 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
WO2017066768A1 (en) 2015-10-16 2017-04-20 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Mullti-component biio-active drug delivery and controlled release to the skin by microneedle array devices
CN108348292B (en) 2015-10-27 2021-04-27 纳诺帕斯技术有限公司 Microneedle device with mechanical guidance
CA3007291C (en) * 2015-12-04 2019-10-22 Ascilion Ab A microneedle and a chip
US11744889B2 (en) 2016-01-05 2023-09-05 University of Pittsburgh—of the Commonwealth System of Higher Education Skin microenvironment targeted delivery for promoting immune and other responses
US11766506B2 (en) 2016-03-04 2023-09-26 Mirus Llc Stent device for spinal fusion
KR101942172B1 (en) 2017-01-11 2019-01-24 가천대학교 산학협력단 Micro-needles, mamufacture apparatus thereof and method of mamufacture using them
DK3606760T3 (en) 2017-03-31 2023-11-06 Vaxxas Pty Ltd ARRANGEMENT AND PROCEDURE FOR COATING SURFACES
US11175128B2 (en) 2017-06-13 2021-11-16 Vaxxas Pty Limited Quality control of substrate coatings
KR20200028395A (en) 2017-06-15 2020-03-16 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) Nanostructured lipid carriers and stable emulsions and their use
EP4218893A1 (en) 2017-08-04 2023-08-02 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (map)
WO2019077519A1 (en) 2017-10-17 2019-04-25 3M Innovative Properties Company Applicator for applying a microneedle array to skin
KR102208178B1 (en) 2017-12-01 2021-01-28 가천대학교 산학협력단 Micro-needles and method of mamufacture
KR20190065003A (en) 2017-12-01 2019-06-11 가천대학교 산학협력단 Micro-needles and method of mamufacture
EP3793440A1 (en) 2018-05-16 2021-03-24 Kindeva Drug Delivery L.P. Microneedle biosensor
US10980993B2 (en) 2018-10-31 2021-04-20 Gachon University Of Industry-Academic Cooperation Foundation Microneedle, apparatus for manufacturing microneedle, and method of manufacturing microneedle using apparatus
US10940554B2 (en) 2018-11-30 2021-03-09 International Business Machines Corporation Planar fabrication of micro-needles
WO2021097347A1 (en) 2019-11-15 2021-05-20 Infectious Disease Research Institute Rig-i agonist and adjuvant formulation for tumor treatment
US11291818B2 (en) * 2020-04-01 2022-04-05 Nanopass Technologies Ltd. Microneedle structure for intradermal injection
AU2021335334A1 (en) 2020-09-04 2023-04-20 Access To Advanced Health Institute Genetically-adjuvanted rna vaccines
AU2021336217A1 (en) 2020-09-04 2023-04-20 Access To Advanced Health Institute Live-attenuated rna hybrid vaccine technology
CA3174411A1 (en) 2020-09-04 2022-03-10 Ryan M. Kramer Co-lyophilized rna and nanostructured lipid carrier
WO2024052882A1 (en) 2022-09-09 2024-03-14 Access To Advanced Health Institute Immunogenic vaccine composition incorporating a saponin

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2409979A (en) * 1946-03-14 1946-10-22 Ralph L Huber Hypodermic needle
US3074403A (en) * 1960-05-17 1963-01-22 American Cyanamid Co Intracutaneous injector with capillary gap
DE2250293A1 (en) * 1972-10-13 1974-04-25 Bayern Freistaat Inoculation stamps for cutaneous smallpox inoculation using dry vaccine
US4561445A (en) * 1983-05-25 1985-12-31 Joseph J. Berke Elongated needle electrode and method of making same
US4969468A (en) * 1986-06-17 1990-11-13 Alfred E. Mann Foundation For Scientific Research Electrode array for use in connection with a living body and method of manufacture
US5468562A (en) * 1991-03-01 1995-11-21 Spire Corporation Metallized polymeric implant with ion embedded coating
US5478328A (en) * 1992-05-22 1995-12-26 Silverman; David G. Methods of minimizing disease transmission by used hypodermic needles, and hypodermic needles adapted for carrying out the method
US5591139A (en) 1994-06-06 1997-01-07 The Regents Of The University Of California IC-processed microneedles
WO1996017648A1 (en) * 1994-12-09 1996-06-13 Novartis Ag Transdermal system
DE19525607A1 (en) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneal drug delivery system
US5801057A (en) * 1996-03-22 1998-09-01 Smart; Wilson H. Microsampling device and method of construction
IE80772B1 (en) * 1996-06-10 1999-02-10 Elan Corp Plc Delivery needle
US6629963B2 (en) * 1996-06-20 2003-10-07 Becton, Dickinson And Company Syringe and needle shield assembly and method of sterilizing such assembly
US5928207A (en) * 1997-06-30 1999-07-27 The Regents Of The University Of California Microneedle with isotropically etched tip, and method of fabricating such a device
AU767122B2 (en) 1998-06-10 2003-10-30 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
GB9815819D0 (en) * 1998-07-22 1998-09-16 Secr Defence Transferring materials into cells and a microneedle array
GB9815820D0 (en) * 1998-07-22 1998-09-16 Secr Defence Improvements relating to micro-machining
US7048723B1 (en) * 1998-09-18 2006-05-23 The University Of Utah Research Foundation Surface micromachined microneedles
GB9911609D0 (en) 1999-05-20 1999-07-21 Advanced Biotech Ltd Improved multi-well plates
US6256533B1 (en) * 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6312612B1 (en) * 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
US6406638B1 (en) * 2000-01-06 2002-06-18 The Regents Of The University Of California Method of forming vertical, hollow needles within a semiconductor substrate, and needles formed thereby
US6375627B1 (en) * 2000-03-02 2002-04-23 Agilent Technologies, Inc. Physiological fluid extraction with rapid analysis
US6558361B1 (en) * 2000-03-09 2003-05-06 Nanopass Ltd. Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
US6440096B1 (en) * 2000-07-14 2002-08-27 Becton, Dickinson And Co. Microdevice and method of manufacturing a microdevice
WO2002015960A2 (en) * 2000-08-21 2002-02-28 The Cleveland Clinic Foundation Microneedle array module and method of fabricating the same
US6533949B1 (en) * 2000-08-28 2003-03-18 Nanopass Ltd. Microneedle structure and production method therefor
US7131987B2 (en) * 2000-10-16 2006-11-07 Corium International, Inc. Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation
US7108681B2 (en) * 2000-10-16 2006-09-19 Corium International, Inc. Microstructures for delivering a composition cutaneously to skin
US6767341B2 (en) * 2001-06-13 2004-07-27 Abbott Laboratories Microneedles for minimally invasive drug delivery
WO2005060621A2 (en) * 2003-11-21 2005-07-07 The Regents Of The University Of California Method and/or apparatus for puncturing a surface for extraction, in situ analysis, and/or substance delivery using microneedles
TWI246929B (en) * 2004-07-16 2006-01-11 Ind Tech Res Inst Microneedle array device and its fabrication method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11717660B2 (en) 2021-07-29 2023-08-08 Nanopass Technologies Ltd. Silicon microneedle structure and production method

Also Published As

Publication number Publication date
AU8248901A (en) 2002-03-13
US6533949B1 (en) 2003-03-18
US20050029223A1 (en) 2005-02-10
WO2002017985A2 (en) 2002-03-07
JP4750347B2 (en) 2011-08-17
EP1330274A2 (en) 2003-07-30
US7850657B2 (en) 2010-12-14
JP2004507371A (en) 2004-03-11
US20100106105A1 (en) 2010-04-29
EP1330274A4 (en) 2007-05-30
US8454844B2 (en) 2013-06-04
AU2001282489B2 (en) 2006-06-22
US7648484B2 (en) 2010-01-19
US20110073560A1 (en) 2011-03-31
CA2420859A1 (en) 2002-03-07
WO2002017985A3 (en) 2003-01-09
EP1330274B1 (en) 2015-11-04

Similar Documents

Publication Publication Date Title
CA2420859C (en) Microneedle structure and production method therefor
AU2001282489A1 (en) Microneedle structure and production method therefor
US6511463B1 (en) Methods of fabricating microneedle arrays using sacrificial molds
US6558361B1 (en) Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
EP2036586B1 (en) Method for manufacturing microneedle
JP5542811B2 (en) Microneedle, microneedle array, and production method thereof
US20040019331A1 (en) Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
AU744470B2 (en) Transdermal probe with an isotropically etched tip, and method of fabricating such a device
US20020188310A1 (en) Microfabricated surgical device
Davis et al. Fabrication and characterization of laser micromachined hollow microneedles
EP1364396A2 (en) Microprotrusion array and methods of making a microprotrusion
CN101342404A (en) Method for manufacturing different-plane metal hollow fine needle for transdermal drug administration
US20130072808A1 (en) Structured probes for neural applications
US6610235B1 (en) Method of fabricating epidermal abrasion device
Ji et al. Microfabricated silicon microneedle array for transdermal drug delivery
US9919916B2 (en) Manufacture of microneedles
EP1276426A2 (en) Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
Sparks et al. Micromachined needles and lancets with design adjustable bevel angles
JP5568234B2 (en) Needle-like body and method for producing needle-like body
CN215585238U (en) Hollow micro-needle array chip
US9526885B1 (en) Microneedles with sharpened tips and corresponding method of fabrication
Talbot Polysilicon micromolding of closed-flow passages for the fabrication of multifunctional microneedles
CN113476735A (en) Hollow microneedle array chip and preparation method thereof
CN115671525A (en) Silicon microneedle structure and method of manufacture
EP2570152A1 (en) Structured probes for neural applications

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20210830